Febuxostat (Uloric) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Febuxostat products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A medication (xanthine oxidase inhibitor) used to lower uric acid and prevent gout attacks.

Products affected

1 / 3

In shortage since

Aug 26, 2024

Reports on file

Talk to a pharmacist

Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.

Book a pharmacist appointment

Need your prescription switched?

If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.

See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage

AURO-FEBUXOSTAT

80MG · TABLET · AURO PHARMA INC

DIN 02533243 · since Aug 26, 2024, no end estimate · Demand increase for the drug.

Resolved

TEVA-FEBUXOSTAT

80MG · TABLET · TEVA CANADA LIMITED

DIN 02466198 · ended Jun 10, 2026 · Disruption of the manufacture of the drug.

Resolved

TEVA-FEBUXOSTAT

80MG · TABLET · TEVA CANADA LIMITED

DIN 02466198 · ended Feb 7, 2024 · Disruption of the manufacture of the drug.

Resolved

TEVA-FEBUXOSTAT

80MG · TABLET · TEVA CANADA LIMITED

DIN 02466198 · ended Jan 10, 2023 · Disruption of the manufacture of the drug.

Discontinued

ULORIC

80MG · TABLET · TAKEDA CANADA INC

DIN 02357380

What's happening

Febuxostat is currently affected by an active shortage report filed with Health Canada by AURO PHARMA INC.

The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Febuxostat is classified under “ANTIGOUT PREPARATIONS” (ATC M04AA).

Recent changes

No changes recorded yet.

Common questions

What is Febuxostat used for?

A medication (xanthine oxidase inhibitor) used to lower uric acid and prevent gout attacks.

When will Febuxostat be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Febuxostat in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antigout preparations)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Colchicine (Myinfla) No current shortage Allopurinol (Zyloprim) Partial shortage 1 of 6 reported products affected Sulfinpyrazone Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.